-
公开(公告)号:US20100272721A1
公开(公告)日:2010-10-28
申请号:US12751474
申请日:2010-03-31
IPC分类号: A61K39/395 , A61P35/00
CPC分类号: C07K16/2875 , A61K2039/505 , C07K16/303 , C07K2317/24
摘要: Methods of treating cancer using an agent that blocks interaction between TWEAK and its receptor are described.
摘要翻译: 描述了使用阻断TWEAK与其受体之间相互作用的试剂治疗癌症的方法。
-
2.
公开(公告)号:US08048635B2
公开(公告)日:2011-11-01
申请号:US11953360
申请日:2007-12-10
IPC分类号: G01N33/53 , G01N33/566 , C07K16/28
CPC分类号: A61K31/573 , A61K31/365 , A61K31/519 , A61K31/52 , A61K31/675 , A61K38/00 , A61K38/177 , A61K39/3955 , A61K45/06 , A61K2039/505 , C07K14/4713 , C07K14/70575 , C07K16/2875 , G01N33/564 , G01N33/6893 , G01N2800/101 , A61K2300/00
摘要: Methods of treating patients and evaluating patients for disease stage and/or severity are disclosed.
摘要翻译: 公开了治疗患者和评估患者疾病阶段和/或严重程度的方法。
-
公开(公告)号:US09730947B2
公开(公告)日:2017-08-15
申请号:US13239769
申请日:2011-09-22
IPC分类号: A61K38/17 , A61K39/00 , A61K39/395 , A61K45/06 , C07K16/28 , G01N33/564 , G01N33/68 , A61K31/573 , C07K14/47 , C07K14/705 , A61K31/365 , A61K31/519 , A61K31/52 , A61K31/675 , A61K38/00
CPC分类号: A61K31/573 , A61K31/365 , A61K31/519 , A61K31/52 , A61K31/675 , A61K38/00 , A61K38/177 , A61K39/3955 , A61K45/06 , A61K2039/505 , C07K14/4713 , C07K14/70575 , C07K16/2875 , G01N33/564 , G01N33/6893 , G01N2800/101 , A61K2300/00
摘要: Methods of treating patients and evaluating patients for disease stage and/or severity are disclosed.
-
公开(公告)号:US20120020970A1
公开(公告)日:2012-01-26
申请号:US13239769
申请日:2011-09-22
IPC分类号: A61K39/395 , A61P13/12 , G01N33/566 , G01N33/577 , C40B30/04 , A61K38/17 , A61P29/00
CPC分类号: A61K31/573 , A61K31/365 , A61K31/519 , A61K31/52 , A61K31/675 , A61K38/00 , A61K38/177 , A61K39/3955 , A61K45/06 , A61K2039/505 , C07K14/4713 , C07K14/70575 , C07K16/2875 , G01N33/564 , G01N33/6893 , G01N2800/101 , A61K2300/00
摘要: Methods of treating patients and evaluating patients for disease stage and/or severity are disclosed.
摘要翻译: 公开了治疗患者和评估患者疾病阶段和/或严重程度的方法。
-
公开(公告)号:US20080279853A1
公开(公告)日:2008-11-13
申请号:US11944714
申请日:2007-11-26
IPC分类号: A61K39/395 , A61P35/00
CPC分类号: C07K16/2875 , A61K2039/505 , C07K16/303 , C07K2317/24
摘要: Methods of treating cancer using an agent that blocks interaction between TWEAK and its receptor are described.
摘要翻译: 描述了使用阻断TWEAK与其受体之间相互作用的试剂治疗癌症的方法。
-
公开(公告)号:US20080292622A1
公开(公告)日:2008-11-27
申请号:US11953360
申请日:2007-12-10
CPC分类号: A61K31/573 , A61K31/365 , A61K31/519 , A61K31/52 , A61K31/675 , A61K38/00 , A61K38/177 , A61K39/3955 , A61K45/06 , A61K2039/505 , C07K14/4713 , C07K14/70575 , C07K16/2875 , G01N33/564 , G01N33/6893 , G01N2800/101 , A61K2300/00
摘要: Methods of treating patients and evaluating patients for disease stage and/or severity are disclosed.
摘要翻译: 公开了治疗患者和评估患者疾病阶段和/或严重程度的方法。
-
7.Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof 有权
标题翻译: 结合蛋白质,包括特异性结合CD154的抗体,抗体衍生物和抗体片段及其用途公开(公告)号:US08293237B2
公开(公告)日:2012-10-23
申请号:US12532517
申请日:2008-03-21
申请人: Linda C. Burkly , Janine L. Ferrant-Orgettas , Ellen A. Garber , Yen-Ming Hsu , Lihe Su , Frederick R. Taylor , Ralph Adams , Derek Thomas Brown , Andrew George Popplewell , Martyn Kim Robinson , Anthony Shock , Kerry Louise Tyson
发明人: Linda C. Burkly , Janine L. Ferrant-Orgettas , Ellen A. Garber , Yen-Ming Hsu , Lihe Su , Frederick R. Taylor , Ralph Adams , Derek Thomas Brown , Andrew George Popplewell , Martyn Kim Robinson , Anthony Shock , Kerry Louise Tyson
IPC分类号: A61K39/395 , C07K16/00 , C12N15/63 , C12N5/10 , C12P21/02
CPC分类号: C07K16/2875 , A61K39/3955 , A61K45/06 , A61K2039/505 , C07K2317/24 , C07K2317/34 , C07K2317/40 , C07K2317/52 , C07K2317/55 , C07K2317/71 , C07K2317/734 , C07K2317/76 , C07K2317/92
摘要: This invention provides binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind a CD154 (CD40L) protein. This invention also provides a chimeric, humanized or fully human antibody, antibody derivative or antibody fragment that specifically binds to an epitope to which a humanized Fab fragment comprising a variable heavy chain sequence according to SEQ ID NO: 1 and comprising a variable light chain sequence according to SEQ ID NO: 2 specifically binds. CD154 binding proteins of this invention may elicit reduced effector function relative to a second anti-CD154 antibody. CD154 binding proteins of this invention are useful in diagnostic and therapeutic methods, such as in the treatment and prevention of diseases including those that involve undesirable immune responses that are mediated by CD154-CD40 interactions.
摘要翻译: 本发明提供特异性结合CD154(CD40L)蛋白的结合蛋白,包括抗体,抗体衍生物和抗体片段。 本发明还提供了嵌合,人源化或完全人抗体,抗体衍生物或抗体片段,其特异性结合包含根据SEQ ID NO:1的可变重链序列的人源化Fab片段的表位,并包含可变轻链序列 根据SEQ ID NO:2特异性结合。 本发明的CD154结合蛋白可以引起相对于第二抗-CD154抗体降低的效应子功能。 本发明的CD154结合蛋白可用于诊断和治疗方法,例如治疗和预防包括由CD154-CD40相互作用介导的不期望的免疫应答的疾病。
-
公开(公告)号:US08048422B2
公开(公告)日:2011-11-01
申请号:US11944709
申请日:2007-11-26
申请人: Linda C. Burkly , Ellen Garber , Alexey Lugovsky
发明人: Linda C. Burkly , Ellen Garber , Alexey Lugovsky
IPC分类号: A61K39/395 , C07K16/24
CPC分类号: C07K16/2875 , A61K2039/505 , C07K2317/24 , C07K2317/76
摘要: Anti-Tweak antibodies are described.
摘要翻译: 描述了抗调节抗体。
-
公开(公告)号:US20090124993A1
公开(公告)日:2009-05-14
申请号:US11816502
申请日:2006-02-17
申请人: Linda C. Burkly , Kyungmin Hahm , Timothy Zheng , Steve Perrin , John Lincecum
发明人: Linda C. Burkly , Kyungmin Hahm , Timothy Zheng , Steve Perrin , John Lincecum
CPC分类号: A61K39/3955 , A61K38/1793 , G01N33/6896 , G01N2800/2814 , G01N2800/2835
摘要: Methods of treating neuronal disorders, such as mechanical neuronal traumas and neurodegenerative disorders, with TWEAK or TWEAK-R blocking agents are presented.
摘要翻译: 提出用TWEAK或TWEAK-R阻断剂治疗神经元疾病如机械神经元创伤和神经退行性疾病的方法。
-
公开(公告)号:US08728475B2
公开(公告)日:2014-05-20
申请号:US13246197
申请日:2011-09-27
申请人: Linda C. Burkly , Timothy Zheng
发明人: Linda C. Burkly , Timothy Zheng
IPC分类号: A61K39/395 , A61K38/16 , A61K38/17
CPC分类号: A61K45/06 , A61K38/177 , A61K38/1793 , A61K39/39541 , A61K2039/505 , C07K16/2875 , C07K2317/56 , G01N2800/102 , A61K2300/00
摘要: Methods of treating inflammatory disorders, such as rheumatoid arthritis, by modulating TWEAK and TNF-α are disclosed, as are other methods.
摘要翻译: 公开了通过调节TWEAK和TNF-α来治疗炎症性疾病如类风湿性关节炎的方法,以及其它方法。
-
-
-
-
-
-
-
-
-